Clinical Trials Directory

Trials / Completed

CompletedNCT01084824

A Trial Examining the Treatment of Common Warts With Combination Liquid Nitrogen (LN2) and Cantharidin

A Randomized Clinical Trial Examining the Efficacy of Treatment of Cutaneous Verruca Vulgaris in Adult Patients With Combined Liquid Nitrogen Cryotherapy and Topically Applied Cantharidin

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
70 (actual)
Sponsor
North Idaho Dermatology · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of the study was to see if liquid nitrogen, a commonly used treatment for warts, is more effective if it is used alone, or if it is more effective if combined with cantharidin, a topical treatment also commonly used for warts (verruca vulgaris).

Conditions

Interventions

TypeNameDescription
DRUGLiquid nitrogen and cantharidinLiquid nitrogen applied to wart(s), then cantharidin 1% topical applied afterward.
DRUGLiquid nitrogen and topical placeboLiquid nitrogen applied to wart(s), then placebo vehicle applied thereafter.

Timeline

Start date
2007-06-01
Primary completion
2008-06-01
Completion
2008-09-01
First posted
2010-03-11
Last updated
2010-03-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01084824. Inclusion in this directory is not an endorsement.

A Trial Examining the Treatment of Common Warts With Combination Liquid Nitrogen (LN2) and Cantharidin (NCT01084824) · Clinical Trials Directory